B P International

The goal of this study is to give a broad review of the most disputed areas of clinical therapeutic help in neonatal and paediatric general and cardiothoracic surgery, as well as pre- and post-operative Intensive Care Unit therapies. This is a description based on protocols and experiments that have been published or are in the midst of being verified in the Neonatal and Pediatric General and Cardiac Anaesthesia and ICU at a Pediatric Hospital in Bari, Italy. Even if science is quick to provide clinicians with new gadgets and therapeutic aims, it is up to the clinicians to use them correctly or, at the very least, alternatively, always keeping the patient's best interests in mind. This is how we function on a daily basis: we strive to adapt new equipment or treatments to the needs of the patients, rather than the patients to the devices or drugs, keeping in mind that developing dedicated systems in the newborn and paediatric age is quite challenging. We have adapted several adu...

Cystic Fibrosis Transmembrane Regulator (CFTR) plays an important role in chloride and thiocyanate ion homeostasis in human epithelial surfaces. Deletion of phenylalanine at position 508 (Δ508) leads to cystic fibrosis and dysregulation of pro-inflammatory cytokines. Pseudomonas aeruginosa gains predominance, contributing over 80% of the lung bacteria in adults with CF and this strongly correlates with the decline of pulmonary function and mortality. The research aimed at understanding the role of CFTR in response to P. aeruginosa, (the most common pathogen that colonises the airways of Cystic Fibrosis patients), with the objectives of evaluating the relative expression of epithelial and inflammatory cytokines (IL-17C and IL-6) in five (Calu3, CFBE41o, CFBE41o wt, Calu3 altered and Calu3 knockout) human bronchial epithelial cell lines after two hours of infection with P. aeruginosa using Quantitative Polymerase Chain Reaction (qPCR). It was found that Calu3 and Calu3 altered, treated ...